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fore, further validation of TBW by segmental BIA During the past 20 years, new techniques have been
developed for obtaining precise and unbiased informa-against a gold standard is required.
tion about three-dimensional structures from two-
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quantify cell hyperplasia
Reply from the authors
To the Editor: We are interested in the recent article We did not use the stereologic method described by
in Kidney International by Hebert et al discussing an Nyengaard to assess hyperplasia because one of our co-
association between patients with proteinuria and proxi- authors, Dr. Mahan, who trained under Dr. Mauer in
mal tubular epithelial cell hyperplasia [1]. We are con- morphometric techniques, determined that we did not
cerned with the method used to quantify cell hyperplasia. have sufficient renal biopsy tissue. The stereologic tech-
The method used produced data related to structure in nique requires multiple sections for analysis, and such
the two-dimensional tissue sections, but it did not gener- material often is not available from needle kidney biop-
ate data allowing deductions regarding the true number sies obtained for clinical purposes.
of tubule cells. With respect to the conclusion of our study, that is, that
The authors, by counting numbers of nuclei on tissue heavy proteinuria is associated with proximal tubular
sections, report an increase in number of nuclei per prox- hyperplasia, we emphasize that this conclusion was based
imal tubule cross-section in patients with increased pro- not only on the morphometric studies, but also on the
teinuria. The authors, in fact, counted the number of qualitative findings on renal biopsy. As shown in Figure
nuclear profiles per proximal tubule cross-section. The 1 of our article, the degree of tubular hyperplasia in
number of particle profiles per tissue area is not directly some patients was extraordinary, with proximal tubular
related to the number of particles per tissue volume. If epithelial cells piling up on one another and encroaching
the volume of the particle is increased or the volume on the tubular lumen. These findings cannot be attrib-
of the tissue decreased (definite possibilities in these uted to a change in nuclear volume or tubular volume,
patients), an increase in profile number per area would which are the concerns of Mr. Basgen and Dr. Mauer.
be expected without any necessary increase in absolute The severity of proximal (and perhaps distal) tubular
cell number. Therefore, this method cannot determine hyperplasia seen in some patients with heavy proteinuria
if true tubular cell number is increased. is remarkable. Indeed, it is amazing that this phenome-
non has not previously been reported, given the scrutiny
often applied to analysis of human renal biopsy material.
It seems likely that tubular hyperplasia contributes toÓ 2001 by the International Society of Nephrology
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progression of renal disease. Also, as we discuss in our
article, it could be the focus of therapeutic interventions
to slow progression of renal disease.
In light of the above, we suggest that the technical
concerns of Mr. Basgen and Dr. Mauer do not invalidate
the conclusions of our article. Nevertheless, their con-
cerns are highly appropriate. Indeed, we endorse their
proposal that scientific journals should adopt the high
standards proposed by Nyengaard for morphometric
studies. Our endorsement, however, is modified in two
respects. First, Nyengaard’s article is too technical. Inves-
tigators may be dissuaded from doing morphometric
studies if they will be judged by the principles contained
in his article. Second, we suggest that a much simpler,
applied version of Nyengaard’s principles should be pub-
lished. Dr. Mauer and his group would be ideal candi-
dates to execute such work. Dr. Mauer is a bellwether
investigator in this field and is noted for his lucid exposi-
tion of data.
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Different response of urinary
excretion of VEGF in patients
with chronic and acute renal
failure
To the Editor: Vascular endothelial growth factor
(VEGF) is constitutively expressed by epithelial cells of
a nephron from embryonic to adult kidneys. In renal
disease, VEGF appears to be involved in a repair of the
glomerulus [1]. It is excreted in urine [2] and is suspected
to be secreted from tubular cells by hypoxic stimulation
in vitro [3, 4] and in vivo [4]. Thus, because the amount
of urinary VEGF might reflect renal hypoxia, we mea-
sured it in patients with renal diseases and various renal
functions.
A total of 29 urine and 26 serum and plasma samples Fig. 1. Relationship of urinary excretion of vascular endothelial
growth factor (VEGF) with 24 hours’ creatinine clearance (CCr) andwere collected from 22 non-diabetic non-nephrotic pa-
serum level of VEGF. (A) VEGF excretion in urine per day vs.tients without serious complications. Fifteen patients had CCr in patients with chronic renal injury. VEGF excretion in urine
a renal biopsy (11 with IgA nephropathy, two with mem- inversely correlated with CCr (simple regression analysis: Y 5 117.2–
0.92X, P 5 0.0003 for the slope; R 5 0.620). (B) VEGF excretionbranous nephropathy, one with focal segmental glomeru-
in urine vs. VEGF level in serum in patients with chronic renal
injury. (C) VEGF excretion in urine per day vs. CCr in patients with
ischemic acute renal failure. The three symbols indicate individual
patients.
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